X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs DR. DATSONS LABS - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD DR. DATSONS LABS BIOCON LTD/
DR. DATSONS LABS
 
P/E (TTM) x 82.9 -10.9 - View Chart
P/BV x 7.8 0.2 4,804.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 BIOCON LTD   DR. DATSONS LABS
EQUITY SHARE DATA
    BIOCON LTD
Mar-17
DR. DATSONS LABS
Mar-14
BIOCON LTD/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs1,162126 925.1%   
Low Rs48331 1,561.5%   
Sales per share (Unadj.) Rs194.6133.0 146.3%  
Earnings per share (Unadj.) Rs34.40.2 22,693.0%  
Cash flow per share (Unadj.) Rs48.36.6 730.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs241.9128.8 187.8%  
Shares outstanding (eoy) m200.0031.66 631.7%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x4.20.6 718.2%   
Avg P/E ratio x23.9516.1 4.6%  
P/CF ratio (eoy) x17.011.8 143.9%  
Price / Book Value ratio x3.40.6 559.5%  
Dividend payout %2.90-   
Avg Mkt Cap Rs m164,4402,477 6,637.6%   
No. of employees `0009.2NA-   
Total wages/salary Rs m7,47056 13,339.3%   
Avg. sales/employee Rs Th4,213.9NM-  
Avg. wages/employee Rs Th809.0NM-  
Avg. net profit/employee Rs Th745.2NM-  
INCOME DATA
Net Sales Rs m38,9114,211 924.1%  
Other income Rs m1,57179 1,996.2%   
Total revenues Rs m40,4824,289 943.8%   
Gross profit Rs m9,795569 1,722.7%  
Depreciation Rs m2,772204 1,356.2%   
Interest Rs m260430 60.4%   
Profit before tax Rs m8,33413 65,622.0%   
Minority Interest Rs m1630-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6166 26,491.8%   
Profit after tax Rs m6,8815 143,354.2%  
Gross profit margin %25.213.5 186.4%  
Effective tax rate %19.448.0 40.4%   
Net profit margin %17.70.1 15,512.1%  
BALANCE SHEET DATA
Current assets Rs m40,4776,852 590.8%   
Current liabilities Rs m16,7836,711 250.1%   
Net working cap to sales %60.93.3 1,818.4%  
Current ratio x2.41.0 236.2%  
Inventory Days Days60161 37.1%  
Debtors Days Days83318 26.0%  
Net fixed assets Rs m45,0733,673 1,227.1%   
Share capital Rs m1,000317 315.9%   
"Free" reserves Rs m47,3773,761 1,259.7%   
Net worth Rs m48,3774,078 1,186.4%   
Long term debt Rs m21,0821,671 1,261.8%   
Total assets Rs m93,94212,633 743.6%  
Interest coverage x33.11.0 3,210.6%   
Debt to equity ratio x0.40.4 106.4%  
Sales to assets ratio x0.40.3 124.3%   
Return on assets %7.63.4 220.8%  
Return on equity %14.20.1 12,082.7%  
Return on capital %12.67.7 164.3%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m12,988964 1,347.3%   
Fx outflow Rs m7,899607 1,301.1%   
Net fx Rs m5,089357 1,425.9%   
CASH FLOW
From Operations Rs m6,4001,345 475.9%  
From Investments Rs m-4,985-2,256 221.0%  
From Financial Activity Rs m-1,775-1,200 147.9%  
Net Cashflow Rs m-473-2,111 22.4%  

Share Holding

Indian Promoters % 40.4 4.5 891.8%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.0 -  
FIIs % 10.7 1.4 792.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 94.1 21.1%  
Shareholders   109,995 20,807 528.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   CIPLA  PFIZER  ALKEM LABORATORIES  ORCHID PHARMA LTD  SANOFI INDIA  

Compare BIOCON LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Firm US Markets; Sun Pharma, Software Stocks & Other Top Cues to Sway the Markets Today(Pre-Open)

Indian share markets finished the previous trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

A New Quest for the Stock Market's MOST Profitable Ideas...(Smart Contrarian)

Feb 23, 2018

If you want to receive the best ideas in the Indian stick markets...you need to heed this important announcement.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Feb 23, 2018 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS